AJP Residents' Journal

About MAOIs- Cameron Kiani interviews Ken Gillman, MD

10.27.2019 - By American Psychiatric Association PublishingPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In this episode, Cameron Kiani interviews Ken Gillman, MD, on using Monoamine Oxidase Inhibitors in clinical practice.   Dr. Gillman is a Queensland-based psychiatrist considered to be one of the world's leading experts on MAOIs. He recently published a statement “Revitalizing monoamine oxidase inhibitors: a call for action” in the journal CNS Spectrums.    Cameron Kiani is a fourth year medical student at Icahn School of Medicine at Mount Sinai with an interest in treatment-resistant mood disorders.    “Revitalizing monoamine oxidase inhibitors: a call for action”   https://www.cambridge.org/core/journals/cns-spectrums/article/revitalizing-monoamine-oxidase-inhibitors-a-call-for-action/32497C0FE4F08D0D4C07E6350A91B0EE

More episodes from AJP Residents' Journal